Wide Berth For Supplement Labeling Claims, But Tight Focus On Violations
This article was originally published in The Tan Sheet
Executive Summary
FDA allows ample room for dietary supplement health claims, including mentions of "common mild symptoms" linked to the aging process, but it will quickly question claims that link a supplement to treating a disease, Anthony Young, general counsel for the American Herbal Products Association, said at a recent industry conference